These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32858923)

  • 1. Effects of Point-Of-Care Testing in General Practice for Type 2 Diabetes Patients on Ambulatory Visits and Hospitalizations.
    Kristensen T; Rose-Olsen K; Volmar Skovsgaard C
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32858923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice.
    Kristensen T; Waldorff FB; Nexøe J; Skovsgaard CV; Olsen KR
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29120361
    [No Abstract]   [Full Text] [Related]  

  • 3. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study.
    Al Hayek AA; Al-Saeed AH; Alzahrani WM; Al Dawish MA
    Diabetes Ther; 2021 Sep; 12(9):2531-2544. PubMed ID: 34363602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.
    Patzer KH; Ardjomand P; Göhring K; Klempt G; Patzelt A; Redzich M; Zebrowski M; Emmerich S; Schnell O
    J Diabetes Sci Technol; 2018 May; 12(3):687-694. PubMed ID: 29532694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study.
    Crocker JB; Lynch SH; Guarino AJ; Lewandrowski K
    J Diabetes Sci Technol; 2021 May; 15(3):561-567. PubMed ID: 33233954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological point of care testing before antibiotic prescribing in primary care: considerable variations between practices.
    Haldrup S; Thomsen RW; Bro F; Skov R; Bjerrum L; Søgaard M
    BMC Fam Pract; 2017 Jan; 18(1):9. PubMed ID: 28125965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative study to explore the views of general practice staff on the use of point-of-care C reactive protein testing for the management of lower respiratory tract infections in routine general practice in England.
    Eley CV; Sharma A; Lecky DM; Lee H; McNulty CAM
    BMJ Open; 2018 Oct; 8(10):e023925. PubMed ID: 30361406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and effect on diabetes control of glycated haemoglobin (HbA1c) point-of-care testing.
    Pillay S; Aldous CM; Singh D; Pillay D
    S Afr Med J; 2019 Jan; 109(2):112-115. PubMed ID: 30834862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries.
    Lingervelder D; Koffijberg H; Emery JD; Fennessy P; Price CP; van Marwijk H; Eide TB; Sandberg S; Cals JWL; Derksen JTM; Kusters R; IJzerman MJ
    Int J Health Policy Manag; 2022 Oct; 11(10):2248-2260. PubMed ID: 34814677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experiences with quality-assured HbA1c and professional glucose point-of-care testing in general practice: a cross-sectional observational study among patients, nurses and doctors.
    Smits M; Hopstaken R; Terhaag L; de Kort G; Giesen P
    BMC Nurs; 2022 Jul; 21(1):183. PubMed ID: 35804341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects.
    Berbudi A; Rahmadika N; Tjahjadi AI; Ruslami R
    J Diabetes Res; 2020; 2020():2037565. PubMed ID: 32733964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between point-of-care testing and venous glucose determination for the diagnosis of diabetes mellitus 6-12 weeks after gestational diabetes.
    Coetzee A; van de Vyver M; Hoffmann M; Hall DR; Mason D; Conradie M
    Diabet Med; 2019 May; 36(5):591-599. PubMed ID: 30663133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of POCT in the diabetic clinic in a large hospital.
    Tanyanyiwa D; Dandara C; Bhana SA; Pauly B; Marule F; Ramokoka M; Bwititi P; Nwose U; Nkosi B
    Afr Health Sci; 2015 Sep; 15(3):902-7. PubMed ID: 26957980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial.
    Laurence CO; Moss JR; Briggs NE; Beilby JJ;
    BMC Health Serv Res; 2010 Jun; 10():165. PubMed ID: 20546629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development over time in point-of-care test use in Danish daytime and out-of-hours general practice: a register-based study.
    Kjær N; Plejdrup Hansen M; Schou Pedersen H; Bondo Christensen M; Huibers L
    Scand J Prim Health Care; 2023 Jun; 41(2):108-115. PubMed ID: 36939231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to hospital-based clinical adoption of point-of-care testing (POCT): A systematic narrative review.
    Quinn AD; Dixon D; Meenan BJ
    Crit Rev Clin Lab Sci; 2016; 53(1):1-12. PubMed ID: 26292075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing point-of-care hemoglobin A1C testing in an obstetrics outpatient clinic.
    Weli H; Farnsworth CW
    Lab Med; 2024 Jul; 55(4):464-470. PubMed ID: 38217552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.